Table 4

Cox regression analysis of MACCE according to levels of pre-CABG, post-CABG 6 hours and post-CABG 24 hours urinary thromboxane metabolite (TXA-M)

TertileUnadjustedAdjusted*
HR95% CIP valuesHR95% CIP values
Pre-CABG10.0750.066
20.540.28~1.010.0550.520.27~1.030.062
30.550.29~1.030.0620.480.25~0.950.036
Post-CABG 6 hours10.7550.564
21.210.64~2.270.5561.330.68~2.220.404
30.920.50~1.880.9230.940.46~1.930.862
Post-CABG 24 hours10.0220.018
22.221.04~4.710.0382.671.20~5.900.016
32.811.35~5.850.0062.861.34~6.130.007
  • Adjusted by all the variables listed in online supplementary table S1 (age, sex, body mass index, current smoking, hypertension, diabetes mellitus, chronic obstructive pulmonary disease, peripheral vascular disease, prior myocardial infarction, chronic kidney disease, ejection fraction, on-pump procedure, aspirin, β-blocker, statins, ACE inhibitors, calcium channel blocker).

  • CABG, coronary artery bypass graft; MACCE, major adverse cardiac and cerebrovascular events.